Suggestions
Gus Schepens
Executive Director, Ulotaront (SEP-856) Worldwide GM at Sunovion Pharmaceuticals
Gus Schepens is the Executive Director and Worldwide General Manager for Ulotaront (SEP-856) at Sunovion Pharmaceuticals. In this role, he oversees the global strategy and operations related to Ulotaront, a novel investigational treatment aimed at addressing unmet needs in psychiatry, particularly in conditions like schizophrenia.
His professional background includes extensive experience in leadership and sales management within the pharmaceutical industry. Gus is recognized for his strategic vision and ability to drive product development and market introduction initiatives effectively. His contributions are pivotal in advancing Sunovion's mission to provide innovative therapies that improve patient outcomes.
For further details about his career and professional achievements, his LinkedIn profile can be found under the username gus-schepens-7942064.
